R&D Systems™ Recombinant Human Flt-3 Ligand, ACFP Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ ACFP308
DescriptionThe Recombinant Human Flt-3 Ligand, ACFP Protein is derived from Sf 9 (baculovirus). The Recombinant Human Flt-3 Ligand, ACFP Protein has been validated for the following applications: Bioactivity.
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.|
|<0.01 EU per 1 μg of the protein by the LAL method.|
|Lyophilized from a 0.2 μm filtered solution in PBS.|
|>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Spodoptera frugiperda,Sf 9 (baculovirus)-derived human Flt-3 Ligand/FLT3L protein Thr27-Pro184 Produced in an animal component free process (ACFP).|
|FL, FLG3L, Flt3 ligand, Flt3L, FLT3LG, fms-related tyrosine kinase 3 ligand, SL cytokine|
|Reconstitute at 100 μg/mL in PBS.|